Literature DB >> 11668015

Regional central nervous system densities of delta-opioid receptors in alcohol-preferring P, alcohol-nonpreferring NP, and unselected Wistar rats.

W N Strother1, E J Chernet, L Lumeng, T K Li, W J McBride.   

Abstract

The densities of delta-opioid receptors in the central nervous system of alcohol-naive, adult, male, alcohol-preferring P, alcohol-nonpreferring NP, and Wistar rats were examined with the use of quantitative autoradiography. Slides with coronal 20-microm sections through the regions of interest were incubated in 5 nM [3H]-[D-Pen(2),D-Pen(5)]enkephalin (DPDPE) to label delta(1)-opioid receptor sites. Nonspecific binding was determined in the presence of 10 microM naloxone. Significant differences between the P and the NP rat lines were found in numerous cortical regions, the basolateral amygdala, and the posterior hippocampus, with 10%-20% lower [3H]-DPDPE binding found in the P line. In most regions examined, binding levels in the Wistar rats were intermediate between those of the P and the NP rats. Significantly lower [3H]-DPDPE binding levels in the P rat may indicate fewer delta(1)-opioid receptors or decreased binding affinity. The lower binding in certain limbic regions, such as the basolateral amygdala and posterior hippocampus, as well as cortical differences in the P rat may be associated with the divergent alcohol drinking behaviors found between the P and the NP lines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668015     DOI: 10.1016/s0741-8329(01)00162-8

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  8 in total

Review 1.  The role of δ-opioid receptors in learning and memory underlying the development of addiction.

Authors:  Paul Klenowski; Michael Morgan; Selena E Bartlett
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 2.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 3.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

4.  Innate differences in protein expression in the nucleus accumbens and hippocampus of inbred alcohol-preferring and -nonpreferring rats.

Authors:  Frank A Witzmann; Junyu Li; Wendy N Strother; William J McBride; Lawrence Hunter; David W Crabb; Lawrence Lumeng; Ting-Kai Li
Journal:  Proteomics       Date:  2003-07       Impact factor: 3.984

5.  Functional gene expression differences between inbred alcohol-preferring and -non-preferring rats in five brain regions.

Authors:  Mark W Kimpel; Wendy N Strother; Jeanette N McClintick; Lucinda G Carr; Tiebing Liang; Howard J Edenberg; William J McBride
Journal:  Alcohol       Date:  2007-03       Impact factor: 2.405

6.  Rat strain differences in brain structure and neurochemistry in response to binge alcohol.

Authors:  Natalie M Zahr; Dirk Mayer; Torsten Rohlfing; Oliver Hsu; Shara Vinco; Juan Orduna; Richard Luong; Richard L Bell; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Psychopharmacology (Berl)       Date:  2013-09-13       Impact factor: 4.530

7.  Acute ethanol effects on local cerebral glucose utilization in select central nervous system regions of adolescent alcohol-preferring (P) and alcohol-nonpreferring (NP) rats.

Authors:  Wendy N Strother; Lawrence Lumeng; William J McBride
Journal:  Alcohol Clin Exp Res       Date:  2008-08-18       Impact factor: 3.455

Review 8.  Delta Opioid Pharmacology in Relation to Alcohol Behaviors.

Authors:  Doungkamol Alongkronrusmee; Terrance Chiang; Richard M van Rijn
Journal:  Handb Exp Pharmacol       Date:  2018
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.